RSS-Feed abonnieren
DOI: 10.1055/a-2102-4796
A Prospective Open-Label Study for Treatment of Infraorbital Hollows Using a Volumizing Hyaluronic Acid Filler
Abstract
This study aimed to prospectively evaluate the effectiveness, patient satisfaction, and early adverse events of using the hyaluronic acid filler VYC-20L for the treatment of infraorbital hollowing. A total of 21 participants underwent injection of VYC-20L. FACE-Q satisfaction surveys before and after treatment along with early adverse events surveys were conducted. Pre- and posttreatment photos were graded, and the Allergan Infraorbital Hollows Scale was used to assess the difference in infraorbital hollowing. The results showed infraorbital hollowing improvement with VYC-20L was significant (p < 0.001). FACE-Q Satisfaction with Eyes scores on average were 27 points higher after treatment (p < 0.001). The mean FACE-Q Satisfaction with Decision score was 74.1%. The most common short-term adverse symptoms were tenderness (67%), swelling (62%), and bruising (52%). This study concludes that VYC-20L is an effective nonsurgical treatment option for infraorbital hollowing with high patient satisfaction.
Publikationsverlauf
Accepted Manuscript online:
30. Mai 2023
Artikel online veröffentlicht:
12. Juli 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Sharad J. Dermal fillers for treatment of tear trough deformity: a review of anatomy, treatment techniques and their outcomes. J Cutan Aesthet Surg 2012; 5 (04) 229-238
- 2 Bravo BSF, Rocha CR, Bastos JT, Silva PM. Comprehensive treatment of periorbital region with hyaluronic acid. J Clin Aesthet Dermatol 2015; 8 (06) 30-35
- 3 Haddock NT, Saadeh PB, Boutros S, Thorne CH. The tear trough and lid/cheek junction: anatomy and implications for surgical correction. Plast Reconstr Surg 2009; 123 (04) 1332-1340
- 4 Donofrio L, Carruthers J, Hardas B. et al. Development and validation of a photonumeric scale for evaluation of infraorbital hollows. Dermatol Surg 2016; 42 (Suppl 1, Suppl 1): S251-S258
- 5 Finn JC, Cox S. Fillers in the periorbital complex. Facial Plast Surg Clin North Am 2007; 15 (01) 123-132 , viii
- 6 American Society of Plastic Surgeons. 2020 National Plastic Surgery Statistics. Updated 2021. Accessed June 28, 2021 at: https://www.plasticsurgery.org/documents/News/Statistics/2020/plastic-surgery-statistics-report-2020.pdf
- 7 Glaser DA, Kenkel JM, Paradkar-Mitragotri D, Murphy DK, Romagnano L, Drinkwater A. Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficit. Dermatol Surg 2015; 41 (08) 942-949
- 8 Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 2006; 22 (05) 335-341 , discussion 341–343
- 9 Steinsapir KD, Steinsapir SMG. Deep-fill hyaluronic acid for the temporary treatment of the naso-jugal groove: a report of 303 consecutive treatments. Ophthal Plast Reconstr Surg 2006; 22 (05) 344-348
- 10 Huber-Vorländer J, Kürten M. Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: a case series. Clin Cosmet Investig Dermatol 2015; 8: 307-312
- 11 Hall MB, Roy S, Buckingham ED. Novel use of a volumizing hyaluronic acid filler for treatment of infraorbital hollows. JAMA Facial Plast Surg 2018; 20 (05) 367-372
- 12 Klassen AF, Cano SJ, Schwitzer JA, Scott AM, Pusic AL. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg 2015; 135 (02) 375-386
- 13 Few J, Cox SE, Paradkar-Mitragotri D, Murphy DK. A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years. Aesthet Surg J 2015; 35 (05) 589-599
- 14 Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 2013; 39 (11) 1602-1612
- 15 U.S. Food and Drug Administration. Juvéderm ® voluma™ xc – p110033/s047. Updated 2021. Accessed June 28, 2021 at: https://www.fda.gov/medical-devices/recently-approved-devices/juvedermr-volumatm-xc-p110033s047
- 16 Callan P, Goodman GJ, Carlisle I. et al. Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 2013; 6: 81-89
- 17 Barone M, Cogliandro A, La Monaca G, Tambone V, Persichetti P. Cognitive investigation study of patients admitted for cosmetic surgery: information, expectations, and consent for treatment. Arch Plast Surg 2015; 42 (01) 46-51
- 18 Diwan Z, Trikha S, Etemad-Shahidi S, Alli Z, Rennie C, Penny A. A prospective study on safety, complications and satisfaction analysis for tear trough rejuvenation using hyaluronic acid dermal fillers. Plast Reconstr Surg Glob Open 2020; 8 (04) e2753
- 19 Berguiga M, Galatoire O. Tear trough rejuvenation: a safety evaluation of the treatment by a semi-cross-linked hyaluronic acid filler. Orbit 2017; 36 (01) 22-26